Financial Performance - The audited net profit attributable to shareholders for 2022 was negative, and the operating revenue was below RMB 100 million, leading to a delisting risk warning for the company's stock [5]. - The company's operating revenue for 2022 was ¥220,838,034.89, representing a 23.82% increase compared to ¥178,349,915 in 2021 [25]. - The net profit attributable to shareholders for 2022 was -¥5,356,486.5, a decrease of 113.40% from ¥39,970,569.46 in 2021 [25]. - The net profit after deducting non-recurring gains and losses was ¥9,338,476.6, down 22.93% from ¥12,117,047 in 2021 [25]. - The company experienced a significant decline in profitability, with a net loss reported for the year [25]. - The company's operating cash flow for 2022 was ¥156,828,635, a significant increase compared to the previous year [26]. - The company's operating revenue for the reporting period was ¥220,838,034.89, representing a 23.82% increase compared to ¥178,349,915.25 in the previous period [46]. - Operating costs increased by 28.76%, reaching ¥176,734,440.33, up from ¥137,257,252.16 in the previous period [46]. - Operating profit decreased significantly by 82.36% to ¥9,380,043.06, primarily due to a large reversal of bad debt provisions in the previous period [46]. - The company has identified uncertainty regarding its ability to continue as a going concern, as indicated by the negative net profit figures over the last three accounting years [29]. Dividend and Shareholder Matters - The company plans not to distribute cash dividends, issue bonus shares, or increase capital using reserves [9]. - The total shares held by six natural person shareholders amounted to 76,498,083 shares, accounting for 22.08% of the total share capital [24]. - The previous controlling shareholder, Hanfu Holdings, was replaced by a new group of shareholders including Boheng Investment and others in November 2019 [24]. - The company has undergone multiple changes in its controlling shareholders since its listing, indicating a dynamic ownership structure [24]. Legal and Contingent Liabilities - The company has a contingent liability due to the arbitration case involving Xie Chuanan, which may lead to potential debt repayment risks [6]. - A compensation of RMB 159 million related to the arbitration case has been agreed upon, with RMB 80 million already paid to the company [7]. - The company is actively following up on the progress of the arbitration and related compensation matters [7]. - The company reported a total estimated liability of RMB 114,391,298.38 as of December 31, 2022, related to a loan dispute involving related parties [160]. - The company is under a court order that involves freezing assets up to RMB 94,140,752.00 due to the loan dispute [157]. - The company is currently involved in arbitration to recover the loan amount and associated interest of approximately 3,938.30137 million RMB [181]. - The company has faced litigation regarding a loan of CNY 13 million, which was primarily used for its mining operations [184]. Audit and Compliance - The annual audit was completed by Zhongxing Caiguanghua Accounting Firm, which issued an unqualified opinion with emphasis on certain matters [5]. - The company has engaged Zhongxing Cai Guanghua Accounting Firm for auditing services during the reporting period [25]. - The audit committee confirmed the compliance of the financial reporting process, ensuring transparency and accuracy in the financial statements [115]. - The company maintained compliance with corporate governance standards as per the requirements of the Company Law and relevant regulations, ensuring no significant discrepancies were found [81]. - The company has established a robust internal management and control system to enhance information disclosure and governance levels [81]. Strategic Direction and Market Expansion - The company has not provided specific guidance for future performance or new product developments in the report [5]. - The company has not disclosed any new strategies for market expansion or mergers and acquisitions in the report [5]. - The company is focusing on strategic transformation into the automotive sales and health industries to cultivate new economic growth points [76]. - The company is exploring potential mergers and acquisitions to strengthen its market position and diversify its portfolio [88]. - The company is exploring market expansion opportunities in Southeast Asia, targeting a 10% market share within the next two years [95]. - The company is committed to innovation, with ongoing research and development initiatives aimed at launching new products in the next fiscal year [88]. Management and Governance - The management team is experienced and professional, which is beneficial for the company's efficient and steady development in the future [45]. - The company has established a clear employee promotion system and allows employees to participate in management decisions through elected supervisors [136]. - The company has taken measures to avoid potential conflicts of interest and ensure fair market practices in related transactions [140]. - The company has committed to avoiding related party transactions unless necessary and ensuring they are conducted at market prices [142]. - The company has actively engaged with investors through multiple communication channels to discuss financial progress and governance updates [80]. Employee and Operational Matters - The total number of employees at the end of the reporting period is 76, with 23 from the parent company and 53 from major subsidiaries [120]. - The educational background of employees includes 2 with postgraduate degrees, 23 with bachelor's degrees, 25 with associate degrees, and 26 with high school or lower education [120]. - The company has implemented a comprehensive human resources system, including employee benefits such as social insurance and housing funds, to safeguard employee rights [136]. Future Outlook - The company provided guidance for 2023, projecting a revenue growth of 15% to 1.725 billion RMB, driven by new product launches and market expansion strategies [100]. - The company has set ambitious growth targets for 2023, with a projected revenue increase of 15% compared to 2022 [88]. - The company is focused on maintaining transparency and governance standards amidst the changes in its leadership [88].

深圳市全新好股份有限公司 2023 年第一季度报告 证券代码：000007 证券简称：全新好 公告编号：2023-026 深圳市全新好股份有限公司 2023 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报 告中财务信息的真实、准确、完整。 3.第一季度报告是否经审计 □是 否 1 深圳市全新好股份有限公司 2023 年第一季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 其他符合非经常性损益定义的损益项目的具体情况 □适用 不适用 公司不存在其他符合非经常性损益定义的损益项目的具体情况。 将《公开发行证券的公司信息披露解释性公告第 1 号——非经常性损益》中列举的非经常 性损益项目界定为经常性损益项目的情况说明 | | 本报告期 | 上年同期 ...

中兴财光华会计师事务所（特殊普通合伙）关于对深交所 公司部关注函〔2023〕第 70 号的回复 深圳证券交易所上市公司管理一部： 深圳市全新好股份有限公司（以下简称"全新好"、"全新好公司"或"公 司"）转来的《关于对深圳市全新好股份有限公司的关注函》公司部关注函〔2023〕 第 70 号（以下简称"《关注函》"）奉悉。作为全新好 2022 年度年审机构，我 们已对贵部在《关注函》中提及的要求我所核查并发表明确意见的事项进行了审 慎核查，现汇报如下： 问题： 2023 年 1 月 19 日，你公司披露的《2022 年年度业绩预告》（以下简称"业 绩预告"）显示，你公司预计 2022 年实现归属于上市公司股东的净利润（以下 简称"净利润"）为 660 万元至 990 万元，扣除非经常性损益后的净利润为 960 万元至 1,390 万元，其中包括债务重组收益 1,312 万元。我部对此表示关注， 请你公司就以下事项进行核实并作出说明： 1.2022 年 10 月 26 日，你公司披露的《2022 年三季度报告》显示，你公司 前三季度实现净利润-893.34 万元。2022 年 12 月 21 日，你公司披露的《关 ...

深圳市全新好股份有限公司 2022 年第三季度报告 证券代码：000007 证券简称：全新好 公告编号：2022-073 深圳市全新好股份有限公司 2022 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度报告是否经过审计 □是 否 1 深圳市全新好股份有限公司 2022 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 深圳市全新好股份有限公司 2022 年第三季度报告 | 减：所得税影响额 | 8,079.37 | 39,431.15 | | | --- | --- | --- | --- | | 少数股东权益影响额 | 41,395.68 | 46,139.11 | | | （税后） | ...

Financial Performance - The company's operating revenue for the first half of 2022 was ¥119,206,368.63, representing a 116.93% increase compared to ¥54,952,028.83 in the same period last year[21]. - The net loss attributable to shareholders was ¥9,989,822.79, a 337.37% increase from a loss of ¥2,284,058.28 in the previous year[21]. - The net cash flow from operating activities was ¥87,308,906.75, a significant improvement of 1,864.58% compared to -¥4,947,863.56 in the same period last year[21]. - The basic earnings per share decreased to -¥0.0288, down 336.36% from -¥0.0066 in the previous year[21]. - The company's total revenue for the first half of 2022 was CNY 119,206,368.6, with a year-on-year increase of 139.00% in domestic revenue[36]. - The net profit attributable to shareholders for the first half of 2022 was 415.98 million yuan, a decrease of 8.0% from the previous year[149]. - The total comprehensive income for the first half of 2022 was a loss of CNY 12,784,639.62, compared to a loss of CNY 1,103,233.02 in the same period of 2021[139]. Assets and Liabilities - Total assets at the end of the reporting period were ¥433,055,004.47, a slight increase of 0.24% from ¥432,015,468.58 at the end of the previous year[21]. - The net assets attributable to shareholders decreased by 9.86% to ¥91,324,620.70 from ¥101,314,443.49 at the end of the previous year[21]. - The company's total liabilities increased to CNY 379,330,896.44 as of June 30, 2022, up from CNY 365,051,143.94 at the beginning of the year, indicating a rise of approximately 3.5%[132]. - The company's total equity turned negative at CNY -1,633,579.43 as of June 30, 2022, a significant decline from CNY 11,151,060.19 at the beginning of the year[132]. - The company's cash and cash equivalents increased significantly to RMB 141,515,963.27 from RMB 59,018,196.77, representing a growth of approximately 139.5%[126]. Business Operations - The automotive sales and services segment generated ¥72,127,095.43, a significant increase of 323.23% from ¥17,042,205.04 in the previous year[34]. - The health industry segment, leveraging patented technology from Japan's Eleten Co., is expected to continue its growth trajectory as market expansion progresses[29]. - The company has identified stable cash flow from its property management and leasing business as a foundation for sustainable development[30]. - The automotive dealership business is still in its early stages but shows potential for further development and enhancement[29]. - The company has experienced a significant increase in sales of sterilization products, with a growth rate of 3,749.21%[34]. Strategic Initiatives - The company plans not to distribute cash dividends or issue bonus shares[7]. - The company is actively pursuing arbitration related to a compensation agreement of ¥159 million with Hanfu Holdings[6]. - The company is exploring new strategies for market expansion and product development to enhance its competitive position[70]. - The company plans to expand its market presence by entering new regions, aiming for a 20% increase in market share by the end of 2023[85]. - The company is investing in new product development, with a budget allocation of RMB 200 million for R&D in 2022[86]. Legal and Compliance Issues - The company has faced various risks in its new business ventures, including market and management risks[3]. - The company is facing potential debt risks due to ongoing litigation, with a joint liability for arbitration cases that may impact financial stability[49]. - The company is actively addressing litigation and arbitration cases to mitigate potential financial losses[69]. - The company has received regulatory warnings due to unfulfilled commitments by certain stakeholders[72]. - The company has committed to fulfilling information disclosure obligations and handling relevant approval processes according to regulations[67]. Shareholder and Governance Matters - The company emphasizes the protection of shareholder rights and adheres to regulatory requirements for transparent information disclosure[59]. - The company has experienced changes in its board of directors, with several resignations and new appointments aimed at strengthening governance[54]. - The major shareholder, Beijing Hongjun Asset Management Co., Ltd., transferred its shares in the company to Hanfu Holdings Co., Ltd., which will not seek control over the company[68]. - The company has committed to avoiding related transactions with Shenzhen Quanxinhao Co., Ltd. in future operations[65]. - The company has not engaged in any related party transactions during the reporting period, including asset or equity acquisitions or sales[88][89][90][91][92][93][94]. Financial Reporting and Audit - The semi-annual financial report has not been audited[75]. - The financial report for the first half of 2022 was not audited[124]. - The company has not reported any changes in accounting policies or prior period error corrections during this reporting period[152]. - The company’s accounting policies comply with the requirements of the enterprise accounting standards, reflecting the financial status and operating results accurately[162].

深圳市全新好股份有限公司 2022 年第一季度报告全文 证券代码：000007 证券简称：*ST 全新 公告编号：2022-040 深圳市全新好股份有限公司 2022 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准 确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带 的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声 明：保证季度报告中财务信息的真实、准确、完整。 3.第一季度报告是否经过审计 □ 是 √ 否 一、主要财务数据 (一)主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增 | | --- | --- | --- | --- | | | | | 减 | | 营业收入（元） | 60,011,228.81 | 13,155,105.20 | 356.18% | | 归属于上市公司股东的净利润（元） | -4,443,902 ...

Financial Performance - The net profit attributable to shareholders, excluding non-recurring gains and losses, was CNY 12,117,047.63, with total operating revenue of CNY 202,545,808.35[5]. - The net profit attributable to shareholders for 2021 was CNY 39,970,569.46, a 132.52% increase from a loss of CNY 122,912,266.31 in 2020[21]. - The net profit after deducting non-recurring gains and losses was CNY 12,117,047.63, up 730.10% from CNY 1,459,702.61 in 2020[21]. - The basic earnings per share for 2021 was CNY 0.1154, compared to a loss of CNY 0.3548 in 2020, marking a 132.53% improvement[22]. - The total assets at the end of 2021 were CNY 432,015,468.58, an 18.56% increase from CNY 364,394,022.55 at the end of 2020[22]. - The net assets attributable to shareholders increased by 57.15% to CNY 101,314,443.49 at the end of 2021 from CNY 64,471,874.03 at the end of 2020[22]. - The company reported a negative cash flow from operating activities of CNY -48,706,064.00 in 2021, worsening from CNY -3,359,064.84 in 2020[21]. - The company achieved an operating profit of ¥42,188,363.88, a turnaround from an operating loss of ¥120,722,431.15 in the previous period[38]. - The company reported a significant increase in sales expenses, which rose by 480.50% to ¥4,967,460.46, primarily due to activities related to automotive sales[52]. Business Operations - The company is expanding into the health industry through its subsidiary Zero Degree Health, which holds patented technology for health products[36]. - The automotive sales business, operated by the subsidiary Yancheng New City Fude Automobile Sales Service Co., contributed significantly to revenue growth[38]. - The company is focusing on strategic transformation, diversifying into automotive sales and health industries, both supported by national policies[37]. - The company expanded its business model to include automotive sales and related services, in addition to its existing property leasing and management operations[48]. - Revenue from automotive sales amounted to ¥100,616,766.58, accounting for 49.68% of total revenue, with no prior year data available[41]. Governance and Compliance - The company has received a corrective order from the Shenzhen Securities Regulatory Bureau and has complied with relevant laws and regulations to improve its governance structure[78]. - The company has established and improved internal management and control systems to enhance information disclosure[78]. - The company’s governance status aligns with the requirements set by the China Securities Regulatory Commission and the Shenzhen Stock Exchange[79]. - The company has made efforts to strengthen its governance level and promote standardized operations[78]. - The company has not reported any significant differences between its governance status and the regulatory requirements[79]. Shareholder Information - The company has no controlling shareholder or actual controller, maintaining independence in assets, personnel, finance, and operations[80]. - The total number of shareholders at the end of the reporting period was 11,064, an increase from 9,849 at the end of the previous month[194]. - Hanfu Holdings Limited holds 14.25% of the company's shares, amounting to 49,382,527 shares, with 25,617 shares being newly pledged or frozen[194]. - The top shareholder, Hanfu Holdings Co., Ltd., holds 49,382,527 shares, accounting for 10.82% of the total shares[195]. - The company does not have a controlling shareholder or actual controller[197][198]. Legal and Arbitration Matters - The company is currently involved in a significant arbitration case with a claim amount of 88.54 million RMB, which has been resolved[156]. - The arbitration ruling requires the company to repay a principal loan of 51 million RMB and interest of approximately 34.97 million RMB[157]. - The company has signed a settlement agreement regarding the arbitration case, which includes a commitment to pay the owed amounts[157]. - The company is pursuing legal action to confirm the validity of agreements related to the transfer of shares and to seek joint liability for economic losses incurred[163]. - The company has faced administrative penalties from the China Securities Regulatory Commission, including warning letters issued to key personnel for their responsibilities in company issues[166]. Future Outlook - The company provided a forward guidance of 20% revenue growth for the upcoming fiscal year, projecting revenues to reach approximately 1.8 billion RMB[136]. - The company plans to invest 300 million RMB in R&D for new technologies over the next two years, focusing on AI and machine learning[134]. - The company aims to reduce operational costs by 15% through efficiency improvements and automation initiatives[136]. - The company is actively seeking to improve its governance structure through the appointment of qualified independent directors[89][90]. - The company is focusing on expanding its market presence and enhancing its product offerings, although specific new products or technologies were not detailed in the reports[88][90].

Financial Performance - The company's operating revenue for the third quarter reached ¥72,894,643.55, representing a significant increase of 492.69% compared to the same period last year[3]. - The company reported a significant increase in sales revenue, totaling ¥127,846,672.38, which is up 280.40% year-on-year[7]. - Total revenue for the third quarter reached ¥127,846,672.38, a significant increase from ¥33,608,786.41 in the same period last year, representing a growth of approximately 279%[23]. - The net profit attributable to shareholders of the listed company was -¥27,900.76, while the net profit after deducting non-recurring gains and losses was ¥2,856,933.36, down 27.60% year-on-year[3]. - The net loss for the quarter was ¥3,085,035.32, an improvement compared to a net loss of ¥45,630,304.85 in the previous year[24]. - The total comprehensive income attributable to the parent company was -2,311,959.04 yuan, compared to -45,516,937.06 yuan in the previous period, indicating a significant improvement[25]. - Basic and diluted earnings per share were both -0.0067 yuan, an improvement from -0.1314 yuan in the previous period[25]. Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥428,618,242.30, reflecting a 17.62% increase from the end of the previous year[3]. - The company's total assets increased to ¥428,618,242.30 from ¥364,394,022.55, reflecting a growth of approximately 17.6%[23]. - Current assets totaled ¥306,301,077.51, up from ¥249,274,875.15, marking an increase of about 22.9%[21]. - Total liabilities rose to ¥354,875,266.25 from ¥296,592,037.45, an increase of about 19.6%[22]. - Total liabilities amounted to CNY 296,592,037.45, with current liabilities at CNY 197,869,885.71 and non-current liabilities at CNY 98,722,151.74[33]. - Owner's equity totaled CNY 67,801,985.10, with attributable equity to shareholders at CNY 64,471,874.03 and minority interests at CNY 3,330,111.07[33]. Cash Flow - The company's cash flow from operating activities showed a net outflow of -¥10,676,842.21 for the year-to-date period[3]. - The net cash flow from operating activities was -10,676,842.21 yuan, worsening from -8,423,439.41 yuan year-over-year[28]. - Cash inflow from operating activities totaled 142,764,401.63 yuan, while cash outflow was 153,441,243.84 yuan, resulting in a net cash outflow of 10,676,842.21 yuan[28]. - The net cash flow from investing activities was 7,934,260.24 yuan, a recovery from -15,234,015.37 yuan in the previous period[28]. - The net cash flow from financing activities was 30,554,016.06 yuan, with total cash inflow of 49,579,800.00 yuan and outflow of 19,025,783.94 yuan[29]. - The ending balance of cash and cash equivalents was 78,856,159.32 yuan, up from 20,100,255.77 yuan in the previous period[29]. - The company's cash and cash equivalents rose to ¥78,944,157.15 from ¥51,169,141.91, a growth of approximately 54.3%[20]. Shareholder Information - The company reported a total of 12,943 common shareholders at the end of the reporting period[10]. - The top ten shareholders held a combined 45.07% of the company's shares, with Hanfu Holdings Co., Ltd. being the largest shareholder at 14.25%[10]. - Hanfu Holdings has reduced its shareholding by 1% (3,450,500 shares) in June 2021 and by 0.59% (2,027,000 shares) in September 2021, without fulfilling the disclosure obligations[15]. Legal and Regulatory Issues - The company reported a negative net profit attributable to shareholders for the year 2020, with operating revenue below RMB 100 million, leading to a delisting risk warning for its stock[12]. - Hanfu Holdings, the largest shareholder, has faced legal issues, including a lawsuit related to compensation for arbitration losses, which may impact the company's financials if the appeal is unsuccessful[12]. - The company is involved in multiple legal disputes, including a loan contract dispute that may require financial provisions, with uncertain outcomes regarding execution suspension requests[17]. Business Developments - A subsidiary has changed its name to Jiangmen Duhuo Paper Technology Co., Ltd., expanding its business scope to include sales of paper products and personal hygiene items[18]. - The company has provided a guarantee of RMB 80 million for a subsidiary's financing related to automotive sales and services[15]. Financial Reporting - The report for the third quarter of 2021 was not audited, which may affect the reliability of the financial data presented[34]. - The company has implemented new leasing standards starting from 2021, which may impact future financial reporting[34]. - The report was released on October 28, 2021, providing insights into the company's performance for the third quarter[35].

Financial Performance - The company's operating revenue for the first half of 2021 was ¥54,952,028.83, representing a 157.87% increase compared to ¥21,309,843.24 in the same period last year[22]. - The net profit attributable to shareholders was -¥2,284,058.28, an improvement of 92.34% from -¥29,809,621.17 in the previous year[22]. - The net cash flow from operating activities was -¥4,947,863.56, showing a 43.23% improvement compared to -¥8,716,208.10 in the same period last year[22]. - The company reported a basic earnings per share of -¥0.0066, improving by 92.33% from -¥0.0860 in the previous year[22]. - The weighted average return on net assets was -3.61%, an improvement of 11.72% from -15.33% in the previous year[22]. - The company reported a net profit of 2,179,363.55 CNY from its subsidiary Shenzhen Zero Seven Property Management Co., with a revenue of 8,807,491 CNY[53]. - The company incurred a net loss of 1,235,728.0 CNY from its subsidiary Shenzhen DeFu United Financial Holdings, with total assets of 63,024,463 CNY[53]. - The company recorded a revenue of 17,042,205 CNY from its subsidiary Yancheng New City Fude Automobile Sales Service, but faced a net loss of 1,312,715.1 CNY[53]. - The company reported a significant increase in revenue, achieving a total of 1.5 billion RMB for the first half of 2021, representing a year-over-year growth of 20%[71]. - The company reported a significant increase in revenue for the first half of 2021, with a total revenue of RMB 500 million, representing a 20% year-over-year growth[78]. Assets and Liabilities - Total assets increased by 12.48% to ¥409,885,879.60 from ¥364,394,022.55 at the end of the previous year[22]. - The net assets attributable to shareholders decreased by 3.54% to ¥62,187,815.75 from ¥64,471,874.03 at the end of the previous year[22]. - Cash and cash equivalents increased to ¥70,048,912.9, representing 17.09% of total assets, up from 14.04% last year, a growth of 3.05%[42]. - Accounts receivable stood at ¥11,886,351.3, accounting for 2.90% of total assets[42]. - Inventory rose to ¥13,260,341.7, making up 3.24% of total assets, an increase of 2.85% from the previous year[42]. - Investment properties decreased to ¥43,019,865.9, now 10.50% of total assets, down by 1.63%[42]. - Fixed assets amounted to ¥45,571,797.6, representing 11.12% of total assets, a decline of 1.56%[42]. - Short-term borrowings were recorded at ¥646,010.00, constituting 0.16% of total assets[42]. - The total value of restricted assets reached ¥43,039,455.78 due to legal issues[45]. - The total liabilities reached CNY 339,031,767.86, which is an increase of around 14.3% from CNY 296,592,037.45[152]. Strategic Initiatives - The company plans not to distribute cash dividends or issue bonus shares[8]. - The company plans to enhance its capabilities in the health sector through acquisitions and partnerships, including a 95% stake acquisition in Jiangmen Dumon Trading[31]. - The company is expanding into the automotive industry through its subsidiary Yancheng Fude, leveraging partnerships to establish a foothold in this new market[31]. - The company is focusing on strategic transformation into the health sector and automotive sales, aiming to create additional value for shareholders[31]. - The company is actively pursuing a strategic transformation by entering the health and automotive industries, with the establishment of subsidiaries Zero Degree Health and Yancheng Fude[57]. - The company is exploring potential mergers and acquisitions to enhance its market position and growth prospects[178]. Risks and Challenges - The company is facing various risks during its business development and transformation, including market, management, technology, and compliance risks[6]. - The company is facing potential operational and debt repayment risks due to ongoing litigation involving significant loans made without proper internal approval[55]. - The company is actively responding to lawsuits and has made provisions for expected liabilities related to these cases[55]. - The company is monitoring the repayment capabilities of other parties involved in the litigation to mitigate potential losses[55]. - The company acknowledges the uncertainty in its strategic transformation and the need to enhance core competitiveness in the face of market changes[57]. Operational Insights - The company has made progress in resolving historical issues and is focusing on the steady development of its subsidiaries[6]. - The company is closely monitoring the COVID-19 situation and has implemented strict health measures to protect employees and operations[57]. - The company emphasizes the importance of employee rights and has implemented measures such as providing social insurance and high-temperature subsidies[66]. - The company has adopted a "green and low-carbon" philosophy, promoting environmentally friendly practices among employees[66]. Future Outlook - The company has outlined a positive outlook for the second half of 2021, projecting a revenue growth of 25% based on current market trends and user acquisition strategies[73]. - New product launches are expected to contribute an additional 300 million RMB in revenue, with a focus on innovative technology solutions[74]. - The company is expanding its market presence, targeting a 10% increase in market share within the next year through strategic partnerships and marketing initiatives[75]. - Ongoing research and development efforts have allocated 200 million RMB towards new technology advancements, aiming to enhance product offerings and operational efficiency[76]. - The company plans to focus on new product development and market expansion strategies in the upcoming quarters[178].

深圳市全新好股份有限公司 2021 年第一季度报告全文 深圳市全新好股份有限公司 2021 年第一季度报告 2021 年 04 月 1 深圳市全新好股份有限公司 2021 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人陆波、主管会计工作负责人陈建梅及会计机构负责人(会计主管 人员)魏翔声明：保证季度报告中财务报表的真实、准确、完整。 2 深圳市全新好股份有限公司 2021 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增 | | --- | --- | --- | --- | | | | | 减 | | 营业收入（元） | 13,155,105.20 | 8,764,876.04 | 50.09% | | 归属于上市公司股东的净利润（元） | -1,289,465.67 | - ...